We use cookies for a better user experience. Read our Privacy Policy

I Agree

Biopharmaceutical Fermentation Systems Market

Biopharmaceutical Fermentation Systems Market (Product - Upstream Products ( Fermenters, Bioprocess Analyzers, Process Monitoring Devices, Culture and Media Preparation, Culture Media, Buffers and Inducers, Other Upstream Products), Downstream Products (Filtration and Separation Systems, Chromatography, Consumables and Accessories, Other Downstream Products); Application - Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics; End use - Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, Food Industry) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Global Biopharmaceutical Fermentation Systems Market: Snapshot

Growing geriatric population rise in inescapability of wearisome diseases over the world, and flood in human administrations utilization drive enthusiasm for biopharmaceuticals. This along these lines is likely going to fuel the advancement of the global biopharmaceutical fermentation systems market during the gauge time period. A couple of pharmaceutical associations are busy with inventive work of creative new plans and characteristic drugs to meet the dismissed accommodating needs. For instance, Biocon, India's greatest, improvement drove, totally fused biopharmaceutical association which positions among top three biosimilars overall players for insulin, has advocated the rh-insulin (recombinant human insulin) through Pichia development advancement. This is the central point that supports the development of global biopharmaceutical fermentation systems market in coming years.

  • Amidst the outbreak of COVID-19, the healthcare sector is adopting new technology that can help the hospitals not just overcoming the current pandemic but also for the future medical emergencies. Owing to the growing adoption of new tools and technologies, the global biopharmaceutical fermentation systems market is projected to grow substantially during the coming years. COVID-19 has become a global pandemic and consumed more than million lives. This has stimulated healthcare companies are developing innovative tools and technologies that can help the doctors and medical officers to overcome the present and future medical emergencies. Owing to this the global biopharmaceutical fermentation systems market is projected to grow exponentially in coming years.
  • The new players of the global biopharmaceutical fermentation systems market are merging and collaborating with some of the established players of the market to overcome this challenge. This strategy allows the new players to accommodate their resource banks with technology and market exposure so that they can have a sustainable future in the global biopharmaceutical fermentation systems market.

Global Biopharmaceutical Fermentation Systems Market: Overview

Fermentation plays a crucial role in the development new drugs. These drugs can help the patients’ in curing diseases like cancer, H1NI viruses and many other epidemic diseases. The demand for developing new drugs has driven the global biopharmaceutical fermentation systems market from 2018 to 2026. The growth of the market is also attributed to the increasing cases of diseases influenza and typhopoid that are caused by viruses. Moreover, the emergence of several unknown viruses requires effective vaccines, the development of these vaccines is also a major factor that propels the growth of global biopharmaceutical fermentation systems market from 2018 to 2026.

The report by Transparency Market research states that the global biopharmaceutical fermentation systems market shall witness a significant growth during the forecast period. According to the report the market is projected to witness a substantial 6.0% CAGR from 2018 to 2026. Moreover the report also states that the market shall reach to the value of US$ 17.6 bn by the end of the duration. The report also cover various facets such as developments, challenges, trends, drivers, and opportunities that are prevalent in global biopharmaceutical fermentation systems market from 2018 to 2026.

As per the report the global biopharmaceutical fermentation systems market is highly fragmented and competitive. This is because the market has some prominent players that are driving the dynamics of global biopharmaceutical fermentation systems market. These players have total control over the market and have significant hold over the global biopharmaceutical fermentation systems market.

biopharmaceutical fermentation systems market

Global Biopharmaceutical Fermentation Systems Market: Trends and Drivers

Increasing Incidences of Chronic Diseases

Increment in geriatric populace, ascend in pervasiveness of interminable illnesses over the world, and flood in human services consumption drive interest for biopharmaceuticals. This thusly is probably going to fuel the development of the global biopharmaceutical fermentation systems market during the estimate time frame. A few pharmaceutical organizations are occupied with innovative work of imaginative new plans and natural medications to meet the neglected helpful needs. For example, Biocon, India's biggest, development drove, completely incorporated biopharmaceutical organization which positions among top three biosimilar worldwide players for insulin, has popularized the rh-insulin (recombinant human insulin) through Pichia maturation innovation. This is the major factor that boosts the growth of global biopharmaceutical fermentation systems market from 2018 to 2026.

Global Biopharmaceutical Fermentation Systems Market: Segmentation

On the basis of application, the recombinant proteins segment dominated the global biopharmaceutical fermentation systems market. High dependence on microbial frameworks for recombinant protein creation contributed toward the main portion of the section. Increment in interest in look into exercises and presentation of new protein therapeutics have fundamentally added to the improvement of recombinant remedial antibodies and proteins. Also, ascend in the quantity of clinical preliminaries in the pharmaceutical business have helped the fragment in recent years. The recombinant proteins fragment is required to overwhelm the market during the figure time frame, attributable to an expanded spotlight on creating imaginative combination protein and immune response tranquilize conjugates items.

Global Biopharmaceutical Fermentation Systems Market: Regional Analysis

The global biopharmaceutical fermentation systems market is dominated by North America and Europe. This is because of the development of new pharmaceutical companies and improving healthcare sector in U.S. and U.K. This is the reason that these regions are dominating the regional front of global biopharmaceutical fermentation systems market from 2018 to 2026.

The global biopharmaceutical fermentation systems market has been segmented as follows:

Product

  • Upstream Products
    • Fermenters
    • Bioprocess Analyzers
    • Process Monitoring Devices
    • Culture & Media Preparation
    • Culture Media, Buffers & Inducers
    • Other Upstream Products
  • Downstream Products
    • Filtration & Separation Systems
    • Chromatography
    • Consumables & Accessories
    • Other Downstream Products

Application

  • Recombinant Proteins
  • Monoclonal Antibodies
  • Antibiotics
  • Probiotics
  • Others (Amino Acids, Enzymes, Polysaccharides, etc.)

End-user

  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Contract Research Organizations
  • Academic Research Institutes
  • Food Industry
  • Others

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Rest of Middle East & Africa

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Biopharmaceutical Fermentation Systems Market

    4. Market Overview
         4.1. Introduction
                4.1.1. Product Type Definition
                4.1.2. Industry Evolution / Developments
         4.2.  Overview
         4.3. Market Dynamics
                4.3.1. Drivers
                4.3.2. Restraints

                4.3.3. Opportunities
                4.3.4. Key Trends
         4.4. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, 2016–2026
                4.4.1. Market Revenue Projections (US$ Mn)
         4.5. Porter’s Five Force Analysis

    5. Market Outlook
         5.1. Price Comparison Analysis (2017)
                5.1.1. By Product
                5.1.2. By Region
         5.2. Key Potential Customers
                5.2.1. Key Potential Customers by Region
         5.3. Key Distributor Analysis
         5.4. Bioprocess Analyzers Segment Analysis & Overview
         5.5.Technological Advancements
         5.6.Key Mergers & Acquisitions

    6. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Product
         6.1. Introduction & Definition
         6.2. Key Findings/Developments
         6.3. Market Value Forecast, by Product, 2016–2026
                6.3.1. Upstream Products
                         6.3.1.1. Bioreactors/Fermenters
                         6.3.1.2. Bioprocess Analyzers
                         6.3.1.3. Process Monitoring Systems
                         6.3.1.4. Media & Culture Preparation
                         6.3.1.5. Culture Media, Buffers & Inducers
                         6.3.1.6. Other Upstream Products
                6.3.2. Downstream Products
                         6.3.2.1. Filtration & Separation
                         6.3.2.2. Chromatography
                         6.3.2.3. Consumables & Accessories
                         6.3.2.4. Other Downstream Products
         6.4. Market Attractiveness, by Product

    7. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Application
         7.1. Introduction & Definition
         7.2. Key Findings/Developments
         7.3. Market Value Forecast, by Application, 2016–2026
                7.3.1. Antibiotics
                7.3.2. Monoclonal Antibodies
                7.3.3. Recombinant Proteins
                7.3.4. Probiotics
                7.3.5. Others
         7.4. Market Attractiveness, by Application

    8. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by End-users
         8.1. Introduction & Definition
         8.2. Key Findings/Developments
         8.3. Market Value Forecast, by End-User, 2016–2026
                8.3.1. Biopharmaceutical Companies
                8.3.2. Contract Manufacturing Organizations
                8.3.3. Contract Research Organizations
                8.3.4. Academic Research Institutes
                8.3.5. Food Industry
                8.3.6. Others
         8.4. Market Attractiveness, by End-User

    9. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Region
         9.1. Key Findings
         9.2. Market Value Forecast, by Region
                9.2.1. North America
                9.2.2. Europe
                9.2.3. Asia Pacific
                9.2.4. Latin America
                9.2.5. Middle East & Africa
         9.3. Market Attractiveness, by Region

    10. North America Biopharmaceutical Fermentation Systems Market Analysis and Forecast
         10.1. Introduction
                10.1.1. Key Findings
         10.2. Market Value Forecast, by Product, 2016–2026
                10.2.1. Upstream Products
                         10.2.1.1. Bioreactors/Fermenters
                         10.2.1.2. Bioprocess Analyzers
                         10.2.1.3. Process Monitoring Systems
                         10.2.1.4. Media & Culture Preparation
                         10.2.1.5. Culture Media, Buffers & Inducers
                         10.2.1.6. Other Upstream Products
                10.2.2. Downstream Products
                         10.2.2.1. Filtration & Separation
                         10.2.2.2. Chromatography
                         10.2.2.3. Consumables & Accessories
                         10.2.2.4. Other Downstream Products
         10.3. Market Value Forecast, by Application, 2016–2026
                10.3.1. Antibiotics
                10.3.2. Monoclonal Antibodies
                10.3.3. Recombinant Proteins
                10.3.4. Probiotics
                10.3.5. Others
         10.4. Market Value Forecast, by End-users, 2016–2026
                10.4.1. Biopharmaceutical Companies
                10.4.2. Contract Manufacturing Organizations
                10.4.3. Contract Research Organizations
                10.4.4. Academic Research Institutes
                10.4.5. Food Industry
                10.4.6. Others
         10.5. Market Value Forecast, by Country, 2016–2026
                10.5.1. U.S.
                10.5.2. Canada
         10.6. Market Attractiveness Analysis
                10.6.1. By Product
                10.6.2. By Application
                10.6.3. By End-user
                10.6.4. By Country

    11. Europe Biopharmaceutical Fermentation Systems Market Analysis and Forecast
         11.1.Introduction
                11.1.1. Key Findings
         11.2.Market Value Forecast, by Product, 2016–2026
                11.2.1. Upstream Products
                         11.2.1.1. Bioreactors Fermenters
                         11.2.1.2. Bioprocess Analyzers
                         11.2.1.3. Process Monitoring Systems
                         11.2.1.4. Media & Culture Preparation
                         11.2.1.5. Culture Media, Buffers & Inducers
                         11.2.1.6. Other Upstream Products
                11.2.2. Downstream Products
                         11.2.2.1. Filtration & Separation
                         11.2.2.2. Chromatography
                         11.2.2.3. Consumables & Accessories
                         11.2.2.4. Other Downstream Products
         11.3.Market Value Forecast, by Application, 2016–2026
                11.3.1. Antibiotics
                11.3.2. Monoclonal Antibodies
                11.3.3. Recombinant Proteins
                11.3.4. Probiotics
                11.3.5. Others
         11.4.Market Value Forecast, by End-users, 2016–2026
                11.4.1. Biopharmaceutical Companies
                11.4.2. Contract Manufacturing Organizations
                11.4.3. Contract Research Organizations
                11.4.4. Academic Research Institutes
                11.4.5. Food Industry
                11.4.6. Others
         11.5.Market Value Forecast, by Country, 2016–2026
                11.5.1. Germany
                11.5.2. France
                11.5.3. U.K.
                11.5.4. Italy
                11.5.5. Spain
                11.5.6. Rest of Europe
         11.6.Market Attractiveness Analysis
                11.6.1. By Product
                11.6.2. By Application
                11.6.3. By End-users
                11.6.4. By Country

    12. Asia Pacific Biopharmaceutical Fermentation Systems Market Analysis and Forecast
         12.1.Introduction
                12.1.1. Key Findings
         12.2.Market Value Forecast, by Product, 2016–2026
                12.2.1. Upstream Products
                         12.2.1.1. Bioreactors/Fermenters
                         12.2.1.2. Bioprocess Analyzers
                         12.2.1.3. Process Monitoring Systems
                         12.2.1.4. Media & Culture Preparation
                         12.2.1.5. Culture Media, Buffers & Inducers
                         12.2.1.6. Other Upstream Products
                12.2.2. Downstream Products
                         12.2.2.1. Filtration & Separation
                         12.2.2.2. Chromatography
                         12.2.2.3. Consumables & Accessories
                         12.2.2.4. Other Downstream Products
         12.3.Market Value Forecast, by Application, 2016–2026
                12.3.1. Antibiotics
                12.3.2. Monoclonal Antibodies
                12.3.3. Recombinant Proteins
                12.3.4. Probiotics
                12.3.5. Others
         12.4.Market Value Forecast, by End-users, 2016–2026
                12.4.1. Biopharmaceutical Companies
                12.4.2. Contract Manufacturing Organizations
                12.4.3. Contract Research Organizations
                12.4.4. Academic Research Institutes
                12.4.5. Food Industry
                12.4.6. Others
         12.5.Market Value Forecast, by Country, 2016–2026
                12.5.1. China
                12.5.2. Japan
                12.5.3. India
                12.5.4. Australia & New Zealand
                12.5.5. Rest of Asia Pacific
         12.6.Market Attractiveness Analysis
                12.6.1. By Product
                12.6.2. By Application
                12.6.3. By End-users
                12.6.4. By Country

    13. Latin America Biopharmaceutical Fermentation Systems Market Analysis and Forecast
         13.1.Introduction
                13.1.1. Key Findings
         13.2.Market Value Forecast, by Product, 2016–2026
                13.2.1. Upstream Products
                         13.2.1.1. Bioreactors/Fermenters
                         13.2.1.2. Bioprocess Analyzers
                         13.2.1.3. Process Monitoring Systems
                         13.2.1.4. Media & Culture Preparation
                         13.2.1.5. Culture Media, Buffers & Inducers
                         13.2.1.6. Other Upstream Products
                13.2.2. Downstream Products
                         13.2.2.1. Filtration & Separation
                         13.2.2.2. Chromatography
                         13.2.2.3. Consumables & Accessories
                         13.2.2.4. Other Downstream Products
         13.3.Market Value Forecast, by Application, 2016–2026
                13.3.1. Antibiotics
                13.3.2. Monoclonal Antibodies
                13.3.3. Recombinant Proteins
                13.3.4. Probiotics
                13.3.5. Others
         13.4.Market Value Forecast, by End-users, 2016–2026
                13.4.1. Biopharmaceutical Companies
                13.4.2. Contract Manufacturing Organizations
                13.4.3. Contract Research Organizations
                13.4.4. Academic Research Institutes
                13.4.5. Food Industry
                13.4.6. Others
         13.5.Market Value Forecast, by Country, 2016–2026
                13.5.1. Brazil
                13.5.2. Mexico
                13.5.3. Rest of Latin America
         13.6.Market Attractiveness Analysis
                13.6.1. By Product
                13.6.2. By Application
                13.6.3. By End-Users
                13.6.4. By Country

    14. Middle East & Africa Biopharmaceutical Fermentation Systems Market Analysis and Forecast
         14.1.Introduction
                14.1.1. Key Findings
         14.2.Market Value Forecast, by Product, 2016–2026
                14.2.1. Upstream Products
                         14.2.1.1. Bioreactors/Fermenters
                         14.2.1.2. Bioprocess Analyzers
                         14.2.1.3. Process Monitoring Systems
                         14.2.1.4. Media & Culture Preparation
                         14.2.1.5. Culture Media, Buffers & Inducers
                         14.2.1.6. Other Upstream Products
                14.2.2. Downstream Products
                         14.2.2.1. Filtration & Separation
                         14.2.2.2. Chromatography
                         14.2.2.3. Consumables & Accessories
                         14.2.2.4. Other Downstream Products
         14.3.Market Value Forecast, by Application, 2016–2026
                14.3.1. Antibiotics
                14.3.2. Monoclonal Antibodies
                14.3.3. Recombinant Proteins
                14.3.4. Probiotics
                14.3.5. Others
         14.4.Market Value Forecast, by End-users, 2016–2026
                14.4.1. Biopharmaceutical Companies
                14.4.2. Contract Manufacturing Organizations
                14.4.3. Contract Research Organizations
                14.4.4. Academic Research Institutes
                14.4.5. Food Industry
                14.4.6. Others
         14.5.Market Value Forecast, by Country, 2016–2026
                14.5.1. GCC Countries
                14.5.2. South Africa
                14.5.3. Rest of Middle East & Africa
         14.6.Market Attractiveness Analysis
                14.6.1. By Product
                14.6.2. By Application
                14.6.3. By End-users
                14.6.4. By Country

    15. Competition Landscape
         15.1.Market Player – Competition Matrix (By Tier and Size of Companies)
         15.2.Market Share Analysis, by Company (2016)
         15.3.Market Footprint Analysis
                15.3.1. By Region
                15.3.2. By Product
         15.4. Competitive Business Strategies
         15.5. Company Profiles
                15.5.1. GE Healthcare
                         15.5.1.1. Company Overview (HQ, Business Segments, Employee  Strength)
                         15.5.1.2. Company Financials
                         15.5.1.3. Growth Strategies
                         15.5.1.4. Recent Events
                         15.5.1.5. SWOT Analysis
                15.5.2. Thermo Fisher Scientific Inc.
                         15.5.2.1. Company Overview (HQ, Business Segments, Employee  Strength)
                         15.5.2.2. Company Financials
                         15.5.2.3. Growth Strategies
                         15.5.2.4. Recent Events
                         15.5.2.5. SWOT Analysis
                15.5.3. Danaher Corporation
                         15.5.3.1. Company Overview (HQ, Business Segments, Employee  Strength)
                         15.5.3.2. Company Financials
                         15.5.3.3. Growth Strategies
                         15.5.3.4. Recent Events
                         15.5.3.5. SWOT Analysis
                15.5.4. Sartorius Stedim Biotech
                         15.5.4.1. Company Overview (HQ, Business Segments, Employee  Strength)
                         15.5.4.2. Company Financials
                         15.5.4.3. Growth Strategies
                         15.5.4.4. Recent Events
                         15.5.4.5. SWOT Analysis
                15.5.5. Merck KGaA
                         15.5.5.1. Company Overview (HQ, Business Segments, Employee  Strength)
                         15.5.5.2. Company Financials
                         15.5.5.3. Growth Strategies
                         15.5.5.4. Recent Events
                         15.5.5.5. SWOT Analysis
                15.5.6. Eppendorf AG
                         15.5.6.1. Company Overview (HQ, Business Segments, Employee  Strength)
                         15.5.6.2. Company Financials
                         15.5.6.3. Growth Strategies
                         15.5.6.4. Recent Events
                         15.5.6.5. SWOT Analysis
                15.5.7. F. Hoffmann-La Roche Ltd.
                         15.5.7.1. Company Overview (HQ, Business Segments, Employee  Strength)
                         15.5.7.2. Company Financials
                         15.5.7.3. Growth Strategies
                         15.5.7.4. Recent Events
                         15.5.7.5. SWOT Analysis
                15.5.8. Nova Biomedicals
                         15.5.8.1. Company Overview (HQ, Business Segments, Employee  Strength)
                         15.5.8.2. Growth Strategies
                         15.5.8.3. Recent Events
                         15.5.8.4. SWOT Analysis
                15.5.9. Lonza
                         15.5.9.1. Company Overview (HQ, Business Segments, Employee  Strength)
                         15.5.9.2. Company Financials
                         15.5.9.3. Growth Strategies
                         15.5.9.4. Recent Events
                         15.5.9.5. SWOT Analysis
                15.5.10. Becton, Dickinson and Company
                         15.5.10.1. Company Overview (HQ, Business Segments, Employee  Strength)
                         15.5.10.2. Company Financials
                         15.5.10.3. Growth Strategies
                         15.5.10.4. Recent Events
                         15.5.10.5. SWOT Analysis

    List of Tables

    Table 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
    Table 02: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
    Table 03: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
    Table 04: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 05: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) & Volume (Units) Forecast, by End-user, 2016–2026
    Table 06: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Region, 2016–2026
    Table 07: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
    Table 08: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Product, 2016–2026
    Table 09: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Product, 2016–2026
    Table 10: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 11: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 12: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country, 2016–2026
    Table 13: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
    Table 14: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Product, 2016–2026
    Table 15: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Product, 2016–2026
    Table 16: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 17: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 18: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 19: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
    Table 20: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
    Table 21: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
    Table 22: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 23: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 24: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 25: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
    Table 26: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
    Table 27: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
    Table 28: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 29: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 30: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 31: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
    Table 32: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
    Table 33: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
    Table 34: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
    Table 35: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
    Table 36: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

    List of Figures

    Figure 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
    Figure 02: Global Biopharmaceutical Fermentation Systems
    Figure 03: Top Three Trends
    Figure 04: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 05: Global Market Value Share, by Product (2017)
    Figure 06: Global Market Value Share, by Application (2017)
    Figure 07: Global Market Value Share, by End-user (2017)
    Figure 08: Global Market Value Share, by Region (2017)
    Figure 09: Global Biopharmaceutical Fermentation System Market, by Key Customers and Region (2017)
    Figure 10: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
    Figure 11: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
    Figure 12: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, Downstream Products, 2017 and 2026
    Figure 13: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Bioreactors/Fermenters, 2016–2026
    Figure 14: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Bioprocess Analyzers, 2016–2026
    Figure 15: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Culture Monitoring Devices, 2016–2026
    Figure 16: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Media & Culture Preparation, 2016–2026
    Figure 17: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Culture Media, Buffers & Inducers, 2016–2026
    Figure 18: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
    Figure 19: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Filtration & Separation, 2016–2026
    Figure 20: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Chromatography, 2016–2026
    Figure 21: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Consumables & Accessories, 2016–2026
    Figure 22: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
    Figure 23: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018–2026
    Figure 24: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018–2026
    Figure 25: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
    Figure 26: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Antibiotics, 2016–2026
    Figure 27: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Monoclonal Antibodies, 2016–2026
    Figure 28: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Recombinant Proteins, 2016–2026
    Figure 29: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Probiotics, 2016–2026
    Figure 30: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
    Figure 31: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018–2026
    Figure 32: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 33: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biopharmaceutical Companies, 2016–2026
    Figure 34: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by CMOs, 2016–2026
    Figure 35: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by CDOs, 2016–2026
    Figure 36: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Academic Research Institutes, 2016–2026
    Figure 37: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Food Industry, 2016–2026
    Figure 38: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
    Figure 39: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 40: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Region, 2017 and 2026
    Figure 41: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Region, 2018–2026
    Figure 42: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 43: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
    Figure 44: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Product, 2017 and 2026
    Figure 45: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Product, 2018 - 2026
    Figure 46: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Product, 2017 and 2026
    Figure 47: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Product, 2018 - 2026
    Figure 48: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
    Figure 49: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018 -2026
    Figure 50: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 51: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 52: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country, 2017 and 2026
    Figure 53: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country, 2018–2026
    Figure 54: Europe Biopharmaceutical Fermentation Systems  Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 55: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
    Figure 56: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Product, 2017 and 2026
    Figure 57: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Product, 2018 - 2026
    Figure 58: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Product, 2017 and 2026
    Figure 59: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Product, 2018 - 2026
    Figure 60: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
    Figure 61: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018 -2026
    Figure 62: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 63: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 64: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 65: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 66: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 67: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
    Figure 68: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
    Figure 69: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018–2026
    Figure 70: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Products, 2017 and 2026
    Figure 71: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018– 2026
    Figure 72: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
    Figure 73: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018–2026
    Figure 74: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 75: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 76: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 77: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 78: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 79: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
    Figure 80: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
    Figure 81: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018–2026
    Figure 82: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Products, 2017 and 2026
    Figure 83: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018–2026
    Figure 84: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
    Figure 85: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018–2026
    Figure 86: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 87: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 88: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 89: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 90: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
    Figure 91: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
    Figure 92: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
    Figure 93: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018–2026
    Figure 94: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Products, 2017 and 2026
    Figure 95: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018–2026
    Figure 96: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
    Figure 97: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018–2026
    Figure 98: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
    Figure 99: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
    Figure 100: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
    Figure 101: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
    Figure 101: Market Footprint Analysis, by Product (Upstream Products)
    Figure 102: Market Footprint Analysis, by Product (Downstream Products)
    Figure 103: Global Biopharmaceutical Fermentation Systems Market Share, by Company, 2017

Google translate

Copyright © Transparency Market Research, Inc. All Rights reserved